Search research articles
Contact Us
Filters
Showing results (11-20 of 43) with videos related to
Page
of 5
Sort By:
Current Cancer Drug Targets
|
March 23, 2004
Transforming Growth Factor-beta superfamily: evaluation as breast cancer biomarkers and preventive agents
V Gupta, D P Harkin, H Kawakubo, et al.
Anesthesia and Analgesia
|
January 1, 1995
Postoperative tracheal extubation
K A Miller, C P Harkin, P L Bailey
Anesthesia and Analgesia
|
December 10, 1999
An unexpected complication during laparoscopic herniorrhaphy
C P Harkin, E W Sommerhaug, K L Mayer
Biochemical Society Transactions
|
October 25, 2007
Role played by BRCA1 in transcriptional regulation in response to therapy
M M Murray, P B Mullan, D P Harkin
Irish Medical Journal
|
September 1, 1990
Metastatic malignant melanoma in pregnancy
K P Harkin, J E Drumm, P O'Brien, et al.
Neuroreport
|
May 27, 1997
The effects of hyper- and hypocarbia on intraparenchymal arterioles in rat brain slices
C P Harkin, W T Schmeling, J P Kampine, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 1, 1995
Zatebradine, a specific bradycardic agent, alters the hemodynamic and left ventricular mechanical actions of levosimendan, a new myofilament calcium sensitizer, in conscious dogs
P S Pagel, C P Harkin, D A Hettrick, et al.
Journal of Cardiovascular Pharmacology
|
August 1, 1995
Systemic and coronary hemodynamic actions and left ventricular functional effects of levosimendan in conscious dogs
C P Harkin, P S Pagel, J P Tessmer, et al.
Journal of Cardiothoracic and Vascular Anesthesia
|
May 4, 2000
Re-evaluation of renal cell carcinoma tumor thrombus extension by intraoperative transesophageal echocardiography
C P Harkin, P F Roberts, R S Nelson, et al.
Anesthesiology
|
October 1, 1994
Levosimendan (OR-1259), a myofilament calcium sensitizer, enhances myocardial contractility but does not alter isovolumic relaxation in conscious and anesthetized dogs
P S Pagel, C P Harkin, D A Hettrick, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 43) with videos related to
Sort By:
Page
of 5
Current Cancer Drug Targets
|
March 23, 2004
Transforming Growth Factor-beta superfamily: evaluation as breast cancer biomarkers and preventive agents
V Gupta, D P Harkin, H Kawakubo, et al.
Anesthesia and Analgesia
|
January 1, 1995
Postoperative tracheal extubation
K A Miller, C P Harkin, P L Bailey
Anesthesia and Analgesia
|
December 10, 1999
An unexpected complication during laparoscopic herniorrhaphy
C P Harkin, E W Sommerhaug, K L Mayer
Biochemical Society Transactions
|
October 25, 2007
Role played by BRCA1 in transcriptional regulation in response to therapy
M M Murray, P B Mullan, D P Harkin
Irish Medical Journal
|
September 1, 1990
Metastatic malignant melanoma in pregnancy
K P Harkin, J E Drumm, P O'Brien, et al.
Neuroreport
|
May 27, 1997
The effects of hyper- and hypocarbia on intraparenchymal arterioles in rat brain slices
C P Harkin, W T Schmeling, J P Kampine, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 1, 1995
Zatebradine, a specific bradycardic agent, alters the hemodynamic and left ventricular mechanical actions of levosimendan, a new myofilament calcium sensitizer, in conscious dogs
P S Pagel, C P Harkin, D A Hettrick, et al.
Journal of Cardiovascular Pharmacology
|
August 1, 1995
Systemic and coronary hemodynamic actions and left ventricular functional effects of levosimendan in conscious dogs
C P Harkin, P S Pagel, J P Tessmer, et al.
Journal of Cardiothoracic and Vascular Anesthesia
|
May 4, 2000
Re-evaluation of renal cell carcinoma tumor thrombus extension by intraoperative transesophageal echocardiography
C P Harkin, P F Roberts, R S Nelson, et al.
Anesthesiology
|
October 1, 1994
Levosimendan (OR-1259), a myofilament calcium sensitizer, enhances myocardial contractility but does not alter isovolumic relaxation in conscious and anesthetized dogs
P S Pagel, C P Harkin, D A Hettrick, et al.
Page
of 5